COVID-19 vaccination timing, relative to acute COVID-19, and subsequent risk of long COVID
Open Access
- 24 July 2026
- journal article
- Published by Elsevier in EBioMedicine
- Vol. 130, 106382
Abstract
No abstract availableKeywords
Funding Information
- Bill and Melinda Gates Foundation
- National Institute of General Medical Sciences
- National Institute of Allergy and Infectious Diseases
- National Institute of Mental Health
This publication has 30 references indexed in Scilit:
- Effectiveness of COVID-19 vaccines against post-COVID-19 condition/long COVID: systematic review and meta-analysisClinical Microbiology and Infection, 2025
- The effect of pre-COVID and post-COVID vaccination on long COVID: A systematic review and meta-analysisJournal of Infection, 2024
- Risk Factors Associated With Post−COVID-19 ConditionJAMA Internal Medicine, 2023
- Evaluation of Waning of SARS-CoV-2 Vaccine–Induced ImmunityJAMA Network Open, 2023
- Effect of prior immunisation with smallpox vaccine for protection against human Mpox: A systematic reviewReviews in Medical Virology, 2023
- Use of the Postacute Sequelae of COVID-19 Diagnosis Code in Routine Clinical Practice in the USJAMA Network Open, 2022
- Impact of COVID-19 vaccination on the risk of developing long-COVID and on existing long-COVID symptoms: A systematic revieweClinicalMedicine, 2022
- Association Between BNT162b2 Vaccination and Long COVID After Infections Not Requiring Hospitalization in Health Care WorkersJAMA, 2022
- Waning effectiveness of COVID-19 vaccinesThe Lancet, 2022
- Association Between Immune Dysfunction and COVID-19 Breakthrough Infection After SARS-CoV-2 Vaccination in the USJAMA Internal Medicine, 2021